Ingredion to sell majority stake in Pakistan affiliate to Nishat Group

Investing.comMonday, September 29, 2025 at 10:20:56 AM
Ingredion to sell majority stake in Pakistan affiliate to Nishat Group
Ingredion has announced the sale of a majority stake in its Pakistan affiliate to Nishat Group, marking a significant move in the food ingredients sector. This deal not only strengthens Nishat Group's position in the market but also allows Ingredion to focus on its core operations. The partnership is expected to enhance product offerings and drive growth in the region, benefiting both companies and their customers.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Trump brags of ‘massive’ oil deal in Pakistan – but drilling has not found any
NegativeFinancial Markets
Donald Trump's recent announcement of a 'massive' oil deal in Pakistan has raised eyebrows among experts and former officials, who point out that there are no indications of untapped oil reserves in the region. This meeting with Pakistan's Prime Minister Shehbaz Sharif and Army Chief Asim Munir marks a significant shift in US-Pakistan relations, but the lack of substance behind the oil deal casts doubt on its viability. It matters because it highlights the complexities of international diplomacy and the challenges of fostering genuine partnerships.
Latest from Financial Markets
Mexico meat sector decries new livestock movement rules, ivermectin requirement to battle screwworm
NegativeFinancial Markets
The meat sector in Mexico is expressing strong opposition to new regulations that impose restrictions on livestock movement and require the use of ivermectin to combat screwworm infestations. These changes are seen as burdensome and could significantly impact the industry, raising concerns about the economic implications for farmers and producers. The situation highlights the ongoing challenges faced by the agricultural sector in adapting to new health measures while maintaining productivity.
Terawulf Inc stock hits 52-week high at 11.79 USD
PositiveFinancial Markets
Terawulf Inc has reached a significant milestone as its stock hits a 52-week high of 11.79 USD. This achievement reflects growing investor confidence and the company's strong performance in the market. Such highs can attract more attention from potential investors, indicating a positive trend for the company's future.
S&P 500 edges higher ahead of upcoming jobs data, possible government shutdown
NeutralFinancial Markets
The S&P 500 has shown a slight increase as investors await crucial jobs data and consider the implications of a potential government shutdown. This uptick reflects market anticipation and uncertainty, highlighting the importance of upcoming economic indicators that could influence future trading decisions.
Trump to head supervisory board in US peace plan for Gaza
PositiveFinancial Markets
Former President Donald Trump is set to lead a supervisory board for a new peace plan aimed at resolving the ongoing conflict in Gaza. The proposal emphasizes an immediate ceasefire and the release of all remaining hostages, which could pave the way for a more stable and peaceful region. This initiative is significant as it highlights a renewed effort to address long-standing tensions and could potentially lead to a breakthrough in negotiations.
TD bank reinstates growth target, focuses on high-fee segments, cost cuts
PositiveFinancial Markets
TD Bank has reinstated its growth target, signaling confidence in its strategy to focus on high-fee segments and implement cost-cutting measures. This move is significant as it reflects the bank's commitment to enhancing profitability and adapting to market demands, which could lead to improved financial performance and shareholder value.
GSK CEO Walmsley to exit as insider Miels tapped to rev up pipeline
PositiveFinancial Markets
GSK is making a significant leadership change as CEO Emma Walmsley steps down, paving the way for insider Thomas Miels to take the helm. This transition is crucial for the company as it aims to revitalize its pipeline of products, which is essential for future growth and innovation. Miels' familiarity with GSK's operations positions him well to drive the company forward, and stakeholders are optimistic about the potential for renewed focus and strategic direction.